Fig. 1From: Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysisThe PRISMA flow chart summarizing the process for the identification of eligible randomized controlled trialsBack to article page